top of page

Neuroscience & Neuroengineering

The neuroscience and neuroengineering research in our lab is centered on aging and dementia, including Alzheimer's disease. Our studies cover a broad range of topics, from risk factors and molecular and cellular mechanisms to therapeutic approaches for treating neurological disorders.

Dietary Risk Factors in AD

Can the food we eat influence the risk of developing Alzheimer's disease (AD)? Research indicates that our diet significantly impacts brain aging and function. We are exploring how dietary factors contribute to the development of aging-related diseases such as AD, and other diseases.
Picture9.png

Supplemental Nutrition for AD

Supplements, including supplemental elements like Magnesium, might help prevent AD or cognitive decline. The speculation is that these dietary add-ons might attack oxidative damage or inflammation, protect nerve cells, or influence other biological processes involved in AD.
Picture10.png

Drugs and Therapeutics for AD

So far, there are no effective drugs to treat or prevent AD. We are developing novel small molecules, therapeutic compounds, peptides, and drugs that target critical pathways involved in dementia and AD.
Picture11_edited.jpg

Adult Neurogenesis

Stem cell therapies have emerged as promising alternatives  for cognitive impairments and neuronal tissue engineering. Cerebral organoids, which are self-organizing 3D cell cultures, demonstrate improved survival rates compared to transplanted stem cells. Consequently, our group is focused on developing cerebral organoids as a novel treatment strategy for brain regeneration in cases of brain injury and neurodegenerative diseases.
Picture13_edited.jpg

The Zhu Lab 

Department of Biomedical Engineering

Stony_Brook_U_logo_horizontal.svg.png
bottom of page